Novo-backed medical device maker Si-Bone has closed a $21m round that will fund its expansion in multiple geographic markets.
US-based medical device producer SI-Bone has closed a $21m funding round led by asset management firm Redline Capital Management that also featured all the company’s existing major investors, including pharmaceutical company Novo.
SI-Bone’s backers also include investment firm Orbimed, venture capital firm Skyline Ventures and private equity firm Montreux Equity Partners.
SI-Bone’s minimally invasive medical device, iFuse Implant System, treats lower back pain caused by disorders of the sacroiliac joint (pictured). The device has gained regulatory approval in both the…
